US Patent 11993644 Antigen binding molecules targeting SARS-CoV-2
Patent 11993644 was granted and assigned to Generate Biomedicines on May, 2024 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11993644 Antigen binding molecules targeting SARS-CoV-2
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.